About 40,000 people with AIDS in the United States are finding that anti-retroviral drugs no longer work.
The drugs turned the disease from a death sentence to a chronic condition and cut the mortality rate sharply. In 2004, 15,798 deaths from AIDS were reported, less than one-third of the 51,000 reported in 1995, The Wall Street Journal reported.
But the drugs are not a cure.
"We've only changed the slope of the disease progression, not halted it altogether, and eventually they do run out of options," Daniel Kuritzkes, associate professor of medicine at Harvard Medical School, told the newspaper.
The next step, for many patients, is salvage therapy. That can include going back to older drugs or searching out experimental treatments.
AIDS is a difficult disease to treat because HIV is a retrovirus that mutates frequently. Some doctors say aggressive treatment in the early days of drug therapy, with patients switching to new ones as soon as they became available, encouraged drug resistance.
Copyright 2006 by United Press International
Related stories:
Victims of Britain's tainted blood scandal speak
(AP) -- Robert Mackie trembles with rage when he describes how he and his wife were kept in the dark about his HIV infection - and how doctors published his medical data in journals years before they gave him the devastating news.
Rare case explains why some infected with HIV remain symptom free without antiretroviral drugs
AIDS experts at Johns Hopkins say they have compelling evidence that some people with HIV who for years and even decades show extremely low levels of the virus in their blood never progress to full-blown AIDS and remain symptom free even without treatment, probably do so because of the strength of their immune systems, not any defects in the strain of HIV that infected them in the first place.
Study offers new insight on HIV transmission risk of men who have sex with men
Approximately half of all new HIV infections in the United States result from the sexual risk behaviors of men who have sex with men. Now, a new study led by a researcher at The Miriam Hospital provides additional insight into which of these men are most likely to transmit HIV to others, potentially paving the way for the development of more targeted prevention programs.
New study finds HIV drug can persist in mothers' milk, increasing risk to them and their babies
A drug commonly used in the developing world to prevent transmission of HIV from mother to child persists in the breast milk and blood of the mothers, putting them and their babies at risk for developing drug-resistant strains of the virus, according to researchers at the Stanford University School of Medicine.
Long-term HIV treatment may reduce risk for atherosclerosis
Antiretroviral drugs for HIV do not increase the risk for coronary atherosclerosis, a central risk factor for heart disease, according to a study led by the University of Pittsburgh Graduate School of Public Health to be published in the Aug. 8 issue of the journal
AIDS and available online today. The results further suggest that antiretroviral therapy may offer men with HIV some protection against atherosclerosis – hardening of the arteries, caused in part by high levels of cholesterol, smoking and other lifestyle factors.
Growth hormone reduces abdominal fat, cardiovascular risk in HIV patients on antiviral therapy
Low-dose growth hormone treatment reduced abdominal fat deposits and improved blood pressure and triglyceride levels in a group of patients with HIV lipodystrophy, a condition involving the redistribution of fat and other metabolic changes in patients receiving combination drug therapy for HIV infection. However, growth hormone treatment appeared to increase blood glucose levels, particularly in those already exhibiting glucose intolerance. The study from researchers at Massachusetts General Hospital (MGH) appears in the Aug.. 6
Journal of the American Medical Association, a special issue on HIV/AIDS.
Sensitive testing reveals drug-resistant HIV with possible consequences for treatment
Drug-resistant HIV at levels too low to be detected by standard tests is not unusual and may contribute to treatment failure, according to research published in
PLoS Medicine.
Researchers disprove long-standing belief about HIV treatment
Researchers at Wake Forest University Baptist Medical Center have disproved a long-standing clinical belief that the hepatitis C virus slows or stunts the immune system's ability to restore itself after HIV patients are treated with a combination of drugs known as the "cocktail."